See also stories tagged with Drug
Search results for synthetic drug
Researchers take the inside route to halt bleeding
Dec 16, 2009 |
4 / 5 (1) |
0
Blood loss is a major cause of death from roadside bombs to freeway crashes. Traumatic injury, the leading cause of death for people age 4 to 44, often overwhelms the body's natural blood-clotting process.
Researchers discover novel method for detecting MIRCERA
Chemistry / Analytical Chemistry
Dec 16, 2009 |
not rated yet |
0
Austrian researchers have successfully developed a new electrophoretic method for detecting MIRCERA® and other erythropoietins (EPO) in the blood. The technique, using SARCOSYL-PAGE, has specifically enhanced sensitivity ...
Nature's fine designs: Scientists find modern lessons in ancient creations
Dec 04, 2009 |
4.5 / 5 (4) |
0
(PhysOrg.com) -- Nature and its bottom-up processes for creating robust and responsive materials are inspiring new generations of synthetic materials and creative design.
New cancer study takes major step toward improved treatment
Dec 01, 2009 |
5 / 5 (2) |
0
Cancer researchers at the University of Oklahoma Health Sciences Center have found a way to turn ineffective new cancer drugs into cancer-fighters. By using their patented chemical compound, SHetA2, researchers tricked cancer ...
New chemical reaction offers opportunities for drug development
Nov 26, 2009 |
5 / 5 (1) |
2
Researchers led by Conway Fellow, Professor Pat Guiry have solved a chemistry problem that has stumped researchers worldwide for more than a decade. The results have earned the group the cover story of the leading scientific ...
Got a pain? -- Have a cup of Brazilian mint
Nov 24, 2009 |
4.6 / 5 (9) |
0
For thousands of years it has been prescribed by traditional healers in Brazil to treat a range of ailments from headaches and stomach pain to fever and flu.
Invention will help speed development of drug treatments for heart failure
Nov 23, 2009 |
not rated yet |
0
Research conducted by University of Minnesota scientists, in collaboration with Celladon Corporation, has led to the invention of technology to more rapidly identify compounds for the treatment of heart failure.
New chemical reaction offers opportunities for drug development
Nov 12, 2009 |
5 / 5 (2) |
0
(PhysOrg.com) -- Scientists at University College Dublin have solved a chemistry problem which has stumped researchers worldwide for more than a decade. The results have earned the group the cover story of the leading scientific ...
The narrow line between love and jealousy
Medicine & Health / Psychology & Psychiatry
Nov 12, 2009 |
5 / 5 (2) |
0
A new study carried out at the University of Haifa has found that the hormone oxytocin, the "love hormone", which affects behaviors such as trust, empathy and generosity, also affects opposite behaviors, such as jealousy ...
Researchers 'notch' a victory toward new kind of cancer drug
Nov 11, 2009 |
4 / 5 (4) |
1
(PhysOrg.com) -- Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Their discovery, published in ...
Findings show nanomedicine promising for treating spinal cord injuries
Nanotechnology / Bio & Medicine
Nov 08, 2009 |
4.5 / 5 (4) |
0
(PhysOrg.com) -- Researchers at Purdue University have discovered a new approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres that could be injected into the blood shortly ...
'Bioidenticals' not FDA-approved, contain estrogen
Medicine & Health / Medications
Oct 25, 2009 |
1 / 5 (1) |
1
(AP) -- Miserable in menopause, Elizabeth Alsgaard pondered an awful choice: Drenching hot flashes or hormone therapies that might raise the risk of cancer. What former actress Suzanne Somers raved about held much more appeal ...
Revealing cancers' weak spots: Researchers exploit genetic 'co-dependence' to kill treatment-resistant tumor cells
Oct 20, 2009 |
5 / 5 (1) |
1
(PhysOrg.com) -- Cancer cells fueled by the mutant KRAS oncogene, which makes them notoriously difficult to treat, can be killed by blocking a more vulnerable genetic partner of KRAS, report scientists at ...
Artificial reddener: New synthetic route for EPO and other glycoprotein analogues
Oct 19, 2009 |
not rated yet |
0
(PhysOrg.com) -- Erythropoetin, abbreviated EPO, has gained a scandalous reputation as a doping agent for racing cyclists. The name is derived from the ancient Greek erythros "red" and poiein “to make”, a fitting designation ...
'Spaghetti' scaffolding could help grow skin in labs
Oct 16, 2009 |
4 / 5 (2) |
0
Scientists are developing new scaffolding technology which could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures. Their research is highlighted in the latest issue of Business, the qu ...
